Medicaid expenditures for children living with smokers
© Levy et al; licensee BioMed Central Ltd. 2011
Received: 24 November 2010
Accepted: 25 May 2011
Published: 25 May 2011
Children's exposure to secondhand smoke is associated with increased morbidity. We estimated Medicaid expenditures for children living with smokers compared to those living with no smokers in the United States.
Data were overall and service-specific (i.e., inpatient, ambulatory, emergency department, prescription drug, and dental) annual Medicaid expenditures for children 0-11 years old from the 2000-2007 Medical Expenditures Panel Surveys. Smokers' presence in households was determined by adult respondents' self reports. There were 25,835 person-years of observation. We used multivariate analyses to adjust for child, parent, and geographic characteristics.
Children with Medicaid expenditures were nearly twice as likely to live with a smoker as other children in the U.S. population. Adjusted analyses revealed no detectable differences in children's overall Medicaid expenditures by presence of smokers in the household. Medicaid children who lived with smokers on average had $10 (95% CI $3, $18) higher emergency department expenditures per year than those living with no smokers.
Living with at least one smoker (a proxy for secondhand smoke exposure) is unrelated to children's overall short-term Medicaid expenditures, but has a modest impact on emergency department expenditures. Additional research is necessary to understand the relationship between secondhand smoke exposure and long-term health and economic outcomes.
One in three children in the U.S. lives with a smoker, and extensive research has established the detrimental effect of secondhand smoke exposure (SHS) on children's health . Because children spend much of their time in the home, outside the sphere of most clean air regulation, they have higher levels and rates of exposure to SHS than adults . Short-term consequences of pediatric exposure to household SHS include increased risk for asthma, bronchitis, bronchiolitis, sinusitis, middle ear infections, and sudden infant death syndrome [2, 4–7]. Longer-term sequelae include reduced lung function and development, and cognitive impairment with specific deficits in reading, math, and visuospacial reasoning [6, 8–12].
Though the adverse health outcomes children face due to SHS exposure are of paramount importance, understanding the relationship between SHS exposure and children's health expenditures is essential to prioritizing scarce health care resources and motivating policy makers to take corrective action. There have been studies estimating the health care costs of children's SHS exposure [13–17]. However, absent from the existing literature is an examination of children's SHS exposure and its relationship to expenditures in the public health insurance programs that cover children in lower income families in the United States: Medicaid and the Children's Health Insurance Program (CHIP). Nearly one third of children in the United States were covered by Medicaid or CHIP in 2005  and low-income children are much more likely to live with a smoker . Thus, the impact of SHS exposure is concentrated in this population. In addition, by focusing on children who (within states) all have the same health insurance, we will remove some of the heterogeneity in ability and propensity to access medical care that may have confounded earlier studies . In the current study, we use the Medical Expenditures Panel Survey (MEPS) to examine the relationship between children's Medicaid/CHIP expenditures and living with a smoker.
Our sample consists of children 0-11 years old who were included in the 2000-2007 rounds of the MEPS, a national survey representative of the non-institutionalized population of the United States. The MEPS is funded by the Agency for Healthcare Research and Quality (AHRQ) and conducted by in-person interview. We focus on children less than 12 years old to reduce the likelihood that a child's tobacco smoke exposure is due to the child's own tobacco use.
Households participating in the MEPS complete five interviews over a two year period and annual response rates ranged from 57-66% over the study time period . Detailed information on demographics, socioeconomic status, health status, health care utilization, insurance coverage, and health expenditures was collected for each household member. Survey staff obtain expenditure data by contacting the providers identified by respondents and requesting information on payments received for services/products provided to the respondent . We included only children who were enrolled in Medicaid for some part of the year (here and henceforth, we use the term Medicaid to indicate Medicaid and CHIP combined). Our analyses were conducted with the person-year as the unit of observation, so our findings relate to average annual medical expenditures per child.
Average annual expenditures for children living with smokers and those not living with smokers were calculated. Because we were primarily interested in the effect of SHS exposure on expenditures to public programs, our primary analyses include only expenditures paid for by Medicaid. Costs borne by other payers, including families' out-of-pocket payments (copayments, coinsurance, deductibles, uninsured care) were excluded. As a sensitivity analysis, we also assessed Medicaid recipients' total health expenditures (not just those paid by Medicaid) as a function of living with a smoker. Multivariate regression models were used to better isolate the effect of living with a smoker on expenditures.
Dollar amounts reflect what providers report was actually paid for medical care, not the price they charged for the care. Expenditures for care delivered under capitated payment arrangements were imputed by AHRQ . We considered both overall expenditures (exclusive of well-child care) and expenditures for specific medical services. Specific services included inpatient care, emergency department care, ambulatory care (exclusive of well-child care), well-child care, dental care, and prescription pharmaceuticals. In all cases, we exclude expenditures for vision care and chiropractic care which should not be causally affected by SHS exposure. We adjust expenditures for inflation to 2007 dollars according to the methods recommended by AHRQ .
The principal independent variable of interest was exposure to SHS. The MEPS does not include any direct measures of children's exposure to SHS, for example serum cotinine levels, so we created a proxy for exposure by determining whether or not there were any smokers in the child's home according to adult respondents' self-reports of smoking ascertained at the midpoint of the survey year. Evidence suggests that living with a smoker is a sensible proxy for SHS exposure, particularly for younger children who spend a greater proportion of their time at home, given the evidence that living with a smoker increases exposure to tobacco smoke. For children, the home is "the dominant site of exposure" . Only 27% of self-reported smokers have strict home smoking bans, while 88% of non-smokers have such a ban . Children living with smokers in homes where there is no home smoking ban have the highest levels of SHS exposure, but even children living with smokers in homes where there is a no smoking rule have SHS exposures that are significantly greater than children who live in households with no smokers at all [24, 25]. As a sensitivity analysis, we also tested whether there was a differential effect according to the number of smokers in the home.
In multivariate analyses, we controlled for a number of potential confounders. We controlled for the child's age, sex, race, and ethnicity. We controlled for family characteristics including mother's age, presence of both parents in the home, household poverty status, and highest education achieved by either parent. Except where well-child care is the dependent variable, we controlled for age-adjusted number of well-child visits. Finally, we controlled for urban/rural location and Census region.
Bivariate differences in the characteristics of children living with or without smokers were assessed using Pearson chi squared statistics. For our regression analyses, we calculated two-part and aggregate models. In the two-part model, part one calculated the probability of any (i.e., non-zero) expenditures using logistic regression. Part two calculated the level of expenditures conditional on having any expenditures using a generalized linear model (GLM). In the aggregate models, we calculated the level of expenditures for all children, not just those with non-zero expenditures, using a GLM. Following current statistical methodology, we assessed a number of modeling strategies and determined that a GLM using a log link and following a Poisson distribution fit the data best [26, 27]. Regression-adjusted mean expenditures and their differences were calculated only for children living with smokers as this is the group that would be affected by changes in household smoking. Using the regression model, we predicted expenditures under the observed scenario that a child lived with smokers and under a counterfactual scenario where the same child did not live with smokers. Mean adjusted annual expenditures in each scenario were calculated as the average of the predicted values. Confidence intervals for the difference across scenarios were calculated by predicting expenditures using the lower and upper limits of the 95% confidence interval for the regression coefficient on the presence of smokers in the home. All statistics were estimated with Stata 10.1 (Stata Corporation, College Station, TX) using balanced repeated replicates to account for the MEPS design characteristics and repeated observations within individuals. The analyses took place in 2010 and 2011.
Because the study involved only publicly available, deidentified data, it was deemed exempt from review by the Massachusetts General Hospital Institutional Review Board.
There were 16,154 unique Medicaid beneficiaries 0-11 years old and 25,835 person-years of observation for the 2000-2007 rounds of the MEPS, representing over 17 million children per year. The average child was enrolled in Medicaid for 10 months of the year, and 65% were enrolled for all 12 months. There was no difference in the duration of Medicaid enrollment between children living with smokers and children with no smokers in the home.
Characteristics of the study population.
0 Smokers in Home
≥1 Smoker in Home
Highest Parent Education
% Fed. Poverty Level
Both parents in household
Estimated annual Medicaid expenditures by presence of smoker in home (2007$)
Smoker in House
Smoker in House
Overall Expenditures c
$213 (-56, 580)
$149 (-68, 427)
90 (-66, 328)
70 (-74, 283)
13 (6, 22)***
10 (3, 18)**
20 (-21, 69)
3 (-41, 56)
51 (8, 111)*
35 (-3, 87)
17 (-2, 44)
13 (-4, 35)
-4 (-12, 6)
-8 (-15, 1)
Adjusting for potential confounders generally attenuated the point estimates for the relationship between Medicaid expenditures and living with a smoker, sometimes substantially. After adjusting for potential confounders, only emergency department expenditures remained significantly associated with living with a smoker, a difference of $10 per child per year (95% CI $3, $18). Apparent differences for prescription drug and dental expenditures were not statistically significant. There was a strong indication that expenditures for well-child care were lower among children living with smokers, but this estimate was also not statistically significant (-$8 per child per year, 95% CI -$15, $1).
Adjusted a two-part and aggregate models of expenditures as a function of presence of smoker in home
Part 1: odds ratio for any expenditures (95% CI)
Part 2: conditional expenditure; GLM coefficient (95% CI)
Overall expenditure: GLM coefficient (95% CI)
Overall Expenditures b
1.09 (0.99, 1.22)
0.14 (-0.13, 0.40)
0.16 (-0.08, 0.40)
0.17 (-0.22, 0.56)
0.20 (0.07, 0.33)**
1.03 (0.95, 1.13)
-0.01 (-0.19, 0.18)
0.01 (-0.18, 0.20)
1.11 (1.02, 1.21)*
0.19 (-0.10, 0.48)
0.27 (-0.02, 0.57)
0.95 (0.82, 1.09)
0.20 (0.04, 0.35)*
0.20 (-0.07, 0.47)
0.98 (0.88, 1.09)
-0.08 (-0.17, 0.01)
-0.10 (-0.21, 0.01)
We estimated models of total health expenditures (regardless of payer) as a function of living with a smoker for overall expenditures and for each separate service (inpatient, emergency, etc.). The statistical significance and relative differences observed for total health expenditures mirror those of Medicaid-paid expenditures, and in some cases (for example, emergency department expenditures) exhibited even smaller differences. Because our findings for total health expenditures are similar to those described above, we do not report them separately.
We also estimated models where smoking status was defined by the number of smokers in the household. Because only 2% of households had 3 or more smokers, we defined household smoking as having 0 smokers, 1 smoker, or 2 or more smokers. We estimated models that assumed a linear relationship with respect to the number of smokers, and models where the three categories of household smokers (0, 1, or ≥2) were included as indicator variables, which would not assume a linear relationship. Both of these models also closely mirrored the findings reported in Tables 2 and 3, so we do not report them separately. Model coefficients indicated higher expenditures for 2 or more smokers compared to one smoker for overall expenditures, inpatient expenditures, emergency department expenditures, and prescription drug expenditures, but none of the estimates were statistically significant.
Using nationally representative survey data, we present the first study examining the relationship between children's Medicaid expenditures and the presence of a smoker in the home. We confirmed that children under 12 and covered by Medicaid were nearly twice as likely to live with a smoker as other children in this age group. Confounding characteristics explained a substantial portion of the difference in medical expenditures between Medicaid children living with or without smokers, and there was no evidence that household smoking was related to children's overall Medicaid expenditures. This is surprising, given the substantial evidence linking SHS exposure to poor child health. We posit that the lack of an observed relationship between household smoking status and health care expenditures may be because the childhood illnesses caused or exacerbated by SHS exposure are not common enough and/or severe enough to raise average medical expenditures. We did see higher emergency department expenditures among children living with smokers, possibly pointing to more/more severe asthma among exposed children. Our estimates of emergency department expenditures included controls for age-adjusted well-child visits, and we found no relationship between non-well-child ambulatory care expenditures and living with a smoker; thus it seems unlikely that the observed increase in emergency department spending simply reflects a substitution from ambulatory to emergency care. We also found that children living with smokers had a higher likelihood of non-zero pharmaceutical costs, potentially due to medications prescribed to treat respiratory illnesses. However, neither of these factors was enough to result in significantly higher overall Medicaid expenditures.
Previous studies in the literature yielded mixed results with respect to the relationship between household smoke exposure and children's medical expenditures. Two of the earliest studies found substantial relationships between household smoking and children's medical expenditures. Aligne and Stoddard estimated that exposure to SHS raises expenditures on children's health care by $203 to $284 per year in 2007 dollars . Their method used a literature review employing separately measured health outcomes and costs, which assumed all adverse health events were treated and that children's healthcare costs for a given condition were identical whether that condition was caused by SHS exposure or not. If these assumptions are invalid, particularly the former, that would bias their findings towards a higher cost of SHS exposure. In addition, at the time of their study (using data prior to 1997), they estimate that more than 50% of children lived with at least one smoker, a figure that is substantially higher than what we observe for children overall. Stoddard and Gray focused on expenditures for respiratory illnesses in children under the age of five who lived with a mother who smoked . Using the 1987 National Medical Expenditures Survey (NMES), the authors found annual expenditures of $156 to $228 per exposed child in 2007 dollars. However, the NMES only has data on what providers charged for medical care, not what they were paid, which is typically much lower. Therefore, NMES data likely overestimate the relationship between SHS exposure and expenditures. A more recent study by Hill and Liang using the MEPS found children 0-4 years old living where smoking took place in the home had $128 per year (2007 dollars) higher expenditures for respiratory conditions than children who had no smoking in the home . As the authors suggest, because the youngest children spend the most time in the home, their exposure levels are likely higher that what would be seen in older children.
Other studies have found no relationship between household smoking and children's health expenditures. McBride et al studied children whose parents were participating in smoking cessation trials in a managed care setting, finding no evidence of increased expenditures for children living with smokers . The study most similar to ours was published by Florence et al . Using the 2000-2003 MEPS, they were also unable to detect any relationship between children's expenditures and living with a smoker when examining all-payer spending for children 0-11 years old. Finding a lower odds of non-zero medical expenditures among children living in households with smokers, the authors posited that unobserved caregiver characteristics (possibly parents' inclination to seek medical care), correlated with both the presence of smokers in the household and children's medical expenditures, might explain the lack of an overall relationship between household smoking and children's medical expenditures. Such an explanation does not appear plausible in our analysis of Medicaid recipients. We find no evidence that children living with smokers have a lower likelihood of having non-zero expenditures than children who do not live with smokers. By restricting our sample to Medicaid recipients, we have a group that is likely more homogeneous on observed and unobserved characteristics, particularly the ability and propensity to access medical care, than the sample studied in Florence et al.'s analysis. While they control for income, education, and insurance coverage, there may be relationships between those variables and the presence of smokers in the household that could not be captured in their model.
Even within our sample of Medicaid recipients, the relationship between children's health expenditures and living with a smoker is highly complex, as evidenced by significant differences in demographic, socioeconomic, and geographic characteristics between children living with no smokers and those living with at least one. Controlling for these factors attenuated the relationship between our exposure measure and medical expenditures, suggesting they are important confounders.
Our analysis should be considered in the context of certain limitations. Most central to our analysis, we did not directly measure exposure to SHS. Nevertheless, we have argued that living with a smoker is a reasonable proxy measure. We focused entirely on the short-term differences in children's expenditures according to whether or not they lived with a smoker. The present study does not address the question of how childhood exposure to SHS affects healthcare spending over the life course. Nor does it consider the effects of in utero exposure, long-term health effects, or potential increases in the likelihood that the child him-/herself eventually becomes a smoker due to the establishment of social norms in the home indicating smoking is acceptable behavior . We also did not examine the extent to which smoking may have contributed to the socioeconomic situation of the family, with the average pack-a-day smoker spending $1800 each year on cigarettes . We focused entirely on expenditures in the context of Medicaid, which are substantially different from the private insurance setting. Lastly, any effect of childhood SHS exposure on cognitive impairment and learning difficulties would lead to SHS-attributable costs that fall outside the health sphere .
The present study indicates that living with at least one smoker, a proxy for increased levels of SHS exposure, is unrelated to children's overall Medicaid expenditures, but may have a modest impact on emergency department expenditures. While reducing Medicaid expenditures does not appear to be a rationale for reducing the number of children living with smokers, the most powerful argument for reducing children's exposure to the toxins in SHS remains reducing childhood morbidity. Additional research is necessary to understand the relationship between secondhand smoke exposure and long-term health and economic outcomes.
List of Abbreviations
Children's Health Insurance Program
Medical Expenditures Panel Survey
Agency for Healthcare Research and Quality
National Medical Expenditures Survey
Acknowledgments and Funding
The authors thank the Flight Attendants Medical Research Institute for their generous support of this project.
- King K, Martynenko M, Bergman MH, Liu YH, Winickoff JP, Weitzman M: Family composition and children's exposure to adult smokers in their homes. Pediatrics. 2009, 123 (4): e559-564. 10.1542/peds.2008-2317.View ArticlePubMedPubMed CentralGoogle Scholar
- USDHHS: The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. 2006, Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and HealthGoogle Scholar
- Bonnie R, Stratton K, Wallace R: Ending the Tobacco Problem: A Blueprint for the Nation. 2007, The National Academies PressGoogle Scholar
- Bek K, Tomac N, Delibas A, Tuna F, Tezic HT, Sungur M: The effect of passive smoking on pulmonary function during childhood. Postgrad Med J. 1999, 75 (884): 339-341.View ArticlePubMedPubMed CentralGoogle Scholar
- Cunningham J, O'Connor GT, Dockery DW, Speizer FE: Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med. 1996, 153 (1): 218-224.View ArticlePubMedGoogle Scholar
- DiFranza JR, Lew RA: Morbidity and mortality in children associated with the use of tobacco products by other people. Pediatrics. 1996, 97 (4): 560-568.PubMedGoogle Scholar
- Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW: Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 1996, 335 (13): 931-937. 10.1056/NEJM199609263351304.View ArticlePubMedGoogle Scholar
- American Academy of Pediatrics: Involuntary smoking--a hazard to children. Pediatrics. 1986, 77: 755-757.Google Scholar
- Etzel RA: Active and passive smoking: hazards for children. Cent Eur J Public Health. 1997, 5 (2): 54-56.PubMedGoogle Scholar
- Gortmaker SL, Walker DK, Jacobs FH, Ruch-Ross H: Parental smoking and the risk of childhood asthma. Am J Public Health. 1982, 72 (6): 574-579. 10.2105/AJPH.72.6.574.View ArticlePubMedPubMed CentralGoogle Scholar
- Mannino DM, Siegel M, Husten C, Rose D, Etzel R: Environmental tobacco smoke exposure and health effects in children: results from the 1991 National Health Interview Survey. Tob Control. 1996, 5 (1): 13-18. 10.1136/tc.5.1.13.View ArticlePubMedPubMed CentralGoogle Scholar
- Yolton K, Dietrich K, Auinger P, Lanphear BP, Hornung R: Exposure to environmental tobacco smoke and cognitive abilities among U.S. children and adolescents. Environ Health Perspect. 2005, 113 (1): 98-103.View ArticlePubMedGoogle Scholar
- Aligne CA, Stoddard JJ: Tobacco and children. An economic evaluation of the medical effects of parental smoking. Arch Pediatr Adolesc Med. 1997, 151 (7): 648-653.View ArticlePubMedGoogle Scholar
- Florence CS, Adams EK, Ayadi MF: Pediatric health care costs attributable to exposure to second-hand smoke: an exploratory analysis. J Health Care Finance. 2007, 34 (1): 36-43.PubMedGoogle Scholar
- Hill SC, Liang L: Smoking in the home and children's health. Tob Control. 2008, 17 (1): 32-37. 10.1136/tc.2007.020990.View ArticlePubMedGoogle Scholar
- McBride CM, Lozano P, Curry SJ, Rosner D, Grothaus LC: Use of health services by children of smokers and nonsmokers in a health maintenance organization. Am J Public Health. 1998, 88 (6): 897-902. 10.2105/AJPH.88.6.897.View ArticlePubMedPubMed CentralGoogle Scholar
- Stoddard JJ, Gray B: Maternal smoking and medical expenditures for childhood respiratory illness. Am J Public Health. 1997, 87 (2): 205-209. 10.2105/AJPH.87.2.205.View ArticlePubMedPubMed CentralGoogle Scholar
- Kaiser Family Foundation: The Medicaid Program at a Glance. 2009, [http://www.kff.org/medicaid/upload/7235_03-2.pdf]Google Scholar
- Agency for Healthcare Research and Quality: MEPS-HC response rates by panel. 2009, [http://meps.ahrq.gov/mepsweb/survey_comp/hc_response_rate.jsp]Google Scholar
- Stagnitti M, Beauregard K, Solis A: Design, Methods, and Field Results of the Medical Expenditure Panel Survey Medical Provider Component (MEPS MPC)--2006 Calendar Year Data. Methodology Report No. 23. Edited by: Quality AfHRa. 2008, Rockville, MDGoogle Scholar
- Agency for Healthcare Research and Quality: MEPS HC-105: 2006 Full Year Consolidated Data File -- Section 22.214.171.124 Expenditures Definition. 2009, [http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h105/h105doc.shtml#25101Expenditures]Google Scholar
- Agency for Healthcare Research and Quality: Using Appropriate Price Indices for Expenditure Comparisons -- Table 1.1.2 Price Index Series. 2009, [http://meps.ahrq.gov/mepsweb/about_meps/Price_Index.shtml#FootnoteT1text3]Google Scholar
- Winickoff JP, Friebely J, Tanski SE, Sherrod C, Matt GE, Hovell MF, McMillen RC: Beliefs about the health effects of "thirdhand" smoke and home smoking bans. Pediatrics. 2009, 123 (1): e74-79. 10.1542/peds.2008-2184.View ArticlePubMedPubMed CentralGoogle Scholar
- Groner JA, Hoshaw-Woodard S, Koren G, Klein J, Castile R: Screening for children's exposure to environmental tobacco smoke in a pediatric primary care setting. Arch Pediatr Adolesc Med. 2005, 159 (5): 450-455. 10.1001/archpedi.159.5.450.View ArticlePubMedGoogle Scholar
- Jarvis MJ, Mindell J, Gilmore A, Feyerabend C, West R: Smoke-free homes in England: prevalence, trends and validation by cotinine in children. Tob Control. 2009, 18 (6): 491-495. 10.1136/tc.2009.031328.View ArticlePubMedGoogle Scholar
- Buntin MB, Zaslavsky AM: Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004, 23 (3): 525-542. 10.1016/j.jhealeco.2003.10.005.View ArticlePubMedGoogle Scholar
- Mullahy J: Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998, 17 (3): 247-281. 10.1016/S0167-6296(98)00030-7.View ArticlePubMedGoogle Scholar
- Farkas AJ, Gilpin EA, White MM, Pierce JP: Association between household and workplace smoking restrictions and adolescent smoking. Jama. 2000, 284 (6): 717-722. 10.1001/jama.284.6.717.View ArticlePubMedGoogle Scholar
- Winickoff JP, Berkowitz AB, Brooks K, Tanski SE, Geller A, Thomson C, Lando HA, Curry S, Muramoto M, Prokhorov AV, et al: State-of-the-art interventions for office-based parental tobacco control. Pediatrics. 2005, 115 (3): 750-760. 10.1542/peds.2004-1055.View ArticlePubMedGoogle Scholar
- Miller T, Rauh VA, Glied SA, Hattis D, Rundle A, Andrews H, Perera F: The economic impact of early life environmental tobacco smoke exposure: early intervention for developmental delay. Environ Health Perspect. 2006, 114 (10): 1585-1588.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/11/125/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.